Recruiting

EXPRESS-VExercise as a Primer for Excitatory Stimulation Study in Vascular Cognitive Impairment No Dementia (EXPRESS-V)

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

tDCS

+ Exercise

+ Treatment as usual

Other
Who is being recruted

Behavior+3

+ Mental Disorders

+ Cognition Disorders

Over 50 Years
+13 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: November 2021
See protocol details

Summary

Principal SponsorSunnybrook Health Sciences Centre
Study ContactMehreen SiddiquiMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: November 22, 2021

Actual date on which the first participant was enrolled.

Vascular disease is a major risk factor and contributor to dementia. Current interventions to manage vascular risk factors have mixed results. Presently, there are no consistently effective treatments targeting vascular cognitive impairment no dementia. Study Aim: To evaluate the effect of exercise-primed tDCS on global cognition. Study Design: Eligible participants will be randomized to one of four interventions: Exercise primer with tDCS, Treatment as usual (TAU/exercise education) with tDCS, or Exercise primer with sham tDCS, Treatment as usual with sham tDCS. Participants randomized to an exercise group will undergo exercise, followed by either sham or active tDCS. Participants randomized to TAU will receive written information in accordance with the Canadian Physical Activity Guidelines for older adults and tDCS or sham. Cognition, behaviour, neuroimaging and blood biomarkers will be measured.

Official TitleExercise as a Primer for Excitatory Stimulation Study in Vascular Cognitive Impairment No Dementia (EXPRESS-V)
Principal SponsorSunnybrook Health Sciences Centre
Study ContactMehreen SiddiquiMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

64 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 50 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

BehaviorMental DisordersCognition DisordersMotor ActivityNeurocognitive DisordersCognitive Dysfunction

Criteria

6 inclusion criteria required to participate
≥50 years of age; females must be post-menopausal

Presence of cerebrovascular and/or cardiovascular risk factors or coronary artery disease

Montreal Cognitive Assessment (MoCA) <27

Sufficiently proficient in English

Show More Criteria

7 exclusion criteria prevent from participating
History of stroke

Change in psychotropics within the last 4 weeks

Current benzodiazepine use due

Metal implants that would preclude safe use of tDCS or neuroimaging

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

4 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Individuals randomized to this group will receive exercise at University Health Network-Toronto Rehabilitation Institute followed by active tDCS.

Group II

Individuals randomized to this group will receive routine advice about physical activity, and active tDCS.

Group III

Individuals randomized to this group will receive exercise at University Health Network-Toronto Rehabilitation Institute followed by sham tDCS.

Group IV

Individuals randomized to this group will receive routine advice about physical activity, and sham tDCS.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Sunnybrook Health Sciences Centre

Toronto, CanadaOpen Sunnybrook Health Sciences Centre in Google Maps
Recruiting
One Study Center